Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/4XC1 stock hub

FRA/4XC1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4XC1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/4XC1FRA/4XC1

—

Loading chart…

In the news

Latest news · FRA/4XC1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4XC1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

147

Groups with data

Currency

USD

Showing 147 of 147 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	275
Employees Change	120%
Employees Change Percent	80
Enterprise value	EUR 1.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.2B
Price	EUR 22.37
Price currency	EUR
Rev Per Employee	227,998.54x
Sic	2836
Symbol	fra/4XC1
Website	https://www.kalvista.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.59%
EV Earnings	-8.53x
EV/FCF	-11.21x
EV/Sales	19.09x
FCF yield	-8.82%
P/B ratio	-522.93x
P/S ratio	19.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-225.86%
EBITDA Margin	-223.88%
Gross margin	25.73%
Gross Profit	EUR 16.1M
Net Income	EUR -139.9M
Pretax Margin	-225.27%
Profit Margin	-223.16%
Profit Per Employee	EUR -508,809
ROCE	-59.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	107.23%
Cagr3y	37.52%
Cagr5y	2.06%
Revenue Growth5 Y	80.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 285.6M
Cash	EUR 255.7M
Current Assets	EUR 271.5M
Current Liabilities	EUR 48.6M
Debt	EUR 242.1M
Debt FCF	EUR -2.27
Equity	EUR -2.3M
Interest Coverage	-8.6
Liabilities	EUR 287.9M
Long Term Assets	EUR 14.2M
Long Term Liabilities	EUR 239.3M
Net Cash	EUR 13.6M
Net Cash By Market Cap	EUR 1.13
Tangible Book Value	EUR -2.3M
Tangible Book Value Per Share	EUR -0.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.58
Net Working Capital	EUR -18.9M
Quick ratio	5.43
Working Capital	EUR 223.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	107.13%
200-day SMA	12.81
3Y total return	160.12%
50-day SMA	16.26
50-day SMA vs 200-day SMA	50over200
5Y total return	10.74%
All Time High	40.6
All Time High Change	-44.9%
All Time High Date	2021-02-09
All Time Low	4.23
All Time Low Change	429.22%
All Time Low Date	2022-10-20
ATR	0.85
Ch YTD	77.54
High	22.37
High52	23.26
High52 Date	2026-04-29
High52ch	-3.83%
Low	22.37
Low52	9
Low52 Date	2025-11-04
Low52ch	148.56%
Ma50ch	37.59%
Price vs 200-day SMA	74.68%
RSI	68.78
RSI Monthly	73.99
RSI Weekly	75.81
Sharpe ratio	1.23x
Sortino ratio	2.44
Total Return	-12.33%
Tr YTD	77.54
Tr1m	30.93%
Tr1w	0.27%
Tr3m	89.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -141.6M
Operating margin	-225.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,586,787%
Net Borrowing	176,862,402.2
Shares Insiders	1.7%
Shares Institutions	93.73%
Shares Qo Q	2.42%
Shares Yo Y	12.33%
Short Ratio	7.39

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -121M
Average Volume	75.5x
Bv Per Share	-0.05
CAPEX	EUR -2.2M
Ch1m	30.93
Ch1w	0.27
Ch1y	107.1
Ch3m	89.58
Ch3y	160.1
Ch5y	10.74
Ch6m	139.3
Change	3.37%
Change From Open	0
Close	21.64
Days Gap	3.37
Depreciation Amortization	1,232,512.8
Earnings Date	2026-07-09
EBIT	EUR -141.6M
EBITDA	EUR -140.4M
EPS	EUR -2.6
F Score	1
FCF	EUR -106.5M
FCF EV Yield	-8.92x
Financing CF	207,782,010
Fiscal Year End	December
Income Tax	EUR -1.3M
Investing CF	23,869,744
Is Primary Listing	0
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Ma150	13.24
Ma150ch	68.92%
Ma20	18.55
Ma20ch	20.57%
Net CF	125,037,651
Next Earnings Date	2026-07-09
Open	22.37
Ppne	10,903,943.4
Price Date	2026-05-08
Relative Volume	3.97x
Revenue	62,699,599x
SBC By Revenue	23.26x
Share Based Comp	14,583,233
Tax By Revenue	-2.1x
Tr6m	139.25%
Z Score	-2.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4XC1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4XC1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4XC1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+93.7%

Share of float held by funds and institutions

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4XC1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.8

Neutral momentum band

Price vs 200-day MA

+74.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4XC1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4XC1 stock rating?

fra/4XC1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4XC1 analysis?

The full report lives at /stocks/fra/4XC1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4XC1?

The latest report frames fra/4XC1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4XC1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.